Anti-obesity pharmacological agents are generally classified into three categories: appetite suppressants, fat absorption inhibitors, and glucagon-like peptide 1 (GLP-1) analogs [13]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.